MARKET WIREStockInvest.us • 1d ago
Amesite Stock Price Forecast. Should You Buy AMST?StockInvest.us report covering Amesite Inc. (AMST) market action, institutional positioning, and fundamental catalysts.
Why AMST Stock advanced +1.48% Today — RQD Quant Desk Flash
$0.57 +1.48% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $0.57
Amesite Inc. (AMST) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $3.7M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on AMST Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is AMST stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Amesite Inc. (NASDAQ: AMST) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $0.57 (+1.48% 1D, market cap $3.7M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 3/20. Across 715 tracked Technology issuers, AMST ranks #569 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does AMST compare to MNDR and WCT in the Technology sector?
▼
Within the Technology sector (Computer Software: Prepackaged Software), AMST carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, MNDR (Mobile-health Network Solutions (Class A)) holds a E grade (27/100 RQD, P/E N/A, ROIC -35.0%, cap $3.6M) and WCT (Wellchange Holdings Company Limited (Class A)) posts a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $3.2M). Among the 5-stock peer group, AMST leads on earnings multiple (N/A) while AMST leads on capital efficiency (-35.0% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for AMST?
▼
Per AMST's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001807166), Amesite Inc. generated $110.5K in revenue (-33.8% YoY), -$6.6M in net income, and -$2.5M in free cash flow against $2.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $0.57 (+0.08%)🧬 Dilution Drag (+1.28% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR RQD RADARRw E · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-12.3% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for AMST)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (32/100 Composite)
🔍 WHY AMST SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+9/20 pts (28% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 52% Gross Margin
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (25% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$0.85-12.9% Next Q
40
Q2 (-2Q)Grade E$0.74-24.3% Next Q
37
Q3 (-1Q)Grade E$0.56+1.8% Next Q
35
CurrentGrade E$0.57-9.2% Hist 90D α
32
Trajectory: D (40) → E (32)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a AMST Turnaround Squeeze
While AMST currently carries a cautious 32/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Technology with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.91) and Max Pain ($0.60) forces dealer call-delta covering toward $3.73.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $AMST• $4.8M Crowd Pool • Kalshi / Polymarket Composite
Contract: “AMST Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why AMST Stock advanced +1.48% Today — RQD Quant Desk Flash
Amesite Inc. (AMST) advanced +1.48% to $0.57, trading at 2% of its 52-week range ($0.52 – $3.55). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($0.52 – $3.55) with RSI-14 at 18.7 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.57 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 52% gross margin and $0 annual free cash flow.
Live AMST Headlines & Catalysts
MARKET WIRETradingView • 1d ago
Amesite Inc. Estimates – NASDAQ:AMSTTradingView report covering Amesite Inc. (AMST) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 40d ago
Amesite Announces New Sales Win Under NurseMagic® Minimum Enterprise Pricing ModelCompany Estimates Agreements at New Pricing Level Can Generate Approximately 85% Gross Margin, Supporting Scalable Growth Across Post-Acute Care OrganizationsDETROIT, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasd
RISK WATCHYahoo Finance • 169d ago
Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise CustomerEnterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute CareDETROIT, May 18, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI-
MARKET WIREYahoo Finance • 190d ago
Amesite Announces Withdrawal of Registration Statement on Form S-1DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST) (the “Company”), a leading developer of AI-powered enterprise solutions, today announced that it has filed with the U.S. Securities and Exchange Com
MARKET WIREYahoo Finance • 190d ago
Amesite reports $6M concurrent registered direct offering, private placementAmesite (AMST) announced that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share in a registered direct offering priced at-t
CATALYSTYahoo Finance • 167d ago
Amesite Stock Soars 150% on New Enterprise Deal. What to Know.Amesite shares soar on a major healthcare AI contract. But there are ample reasons to avoid chasing the momentum in AMST shares today.
MARKET WIREYahoo Finance • 168d ago
Amesite Rips 250% On Its Largest AI Healthcare DeploymentAmesite secured a new enterprise customer representing an approximately 2,700-patient census for NurseMagic AI documentation.
MARKET WIREYahoo Finance • 190d ago
Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules$2 million upfront with up to approximately $4 million of potential aggregate proceeds upon the exercise in full of warrantsDETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI‑nat
MARKET WIREYahoo Finance • 168d ago
Amesite shares skyrocket after landing largest enterprise client to date (AMST)NurseMagic platform selected for large-scale healthcare deploymentAmesite Inc. (NASDAQ:AMST) shares soared 190% in premarket trading Tuesday after the company announced it had secured its largest enterprise customer so f
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AMST)
- ✓Walkthrough of AMST's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
AMST // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -43.00%🛡️ HOLDING TREND SUPPORT
2026-11-03O $0.57H $0.57L $0.56C $0.57VOL 42.0K
RES: $1.16SUP: $0.51SMA50: $0.91SMA200: $1.31
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
AMST Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth
vs. -33.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on AMST today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for AMST. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for AMST today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AMST)
Technology Rank #569 of 715
⚔️ MNDR vs AMST Full Matrix →
1. Head-to-Head Technology Peer Comparison (AMST vs. MNDR, WCT, TAOP, DFSC)
Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)Across 715 tracked Technology securities in the Roarable RQD universe, Amesite Inc. (AMST) ranks #569 by composite RQD confidence (32/100, grade E) and #681 by equity capitalization ($3.7M). Within this direct 5-issuer industry benchmark cohort, AMST leads on earnings valuation at N/A trailing P/E, while AMST leads on capital efficiency and profitability with -35.0% ROIC and — gross margin. DFSC currently holds the highest overall quantitative score in the immediate peer group at 46/100 (D) compared with AMST at 32/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| AMST
ACTIVE
Amesite Inc. | E | 32/100 | — | — | -35.0% | +1.48% | $3.7M | Benchmark Subject |
| MNDR Mobile-health Network Solutions (Class A) | E | 27/100 | — | 16.7% | -35.0% | -2.01% | $3.6M | /mndr-vs-amst → |
| WCT Wellchange Holdings Company Limited (Class A) | E | 19/100 | — | 42.7% | -35.0% | -6.36% | $3.2M | /wct-vs-amst → |
| TAOP Taoping Inc. | E | 31/100 | — | 10.9% | -35.0% | +4.14% | $3.1M | /taop-vs-amst → |
| DFSC DEFSEC Technologies Inc. | D | 46/100 | — | — | — | -13.45% | $3.1M | /dfsc-vs-amst → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0001807166 ↗In its most recent audited fiscal period (FY2025, filed 2025-06-30), Amesite Inc. (AMST) reported GAAP revenue of $110.5K (-33.8% vs. FY2024 revenue of $166.9K , and -86.9% cumulative change since FY2023) , GAAP net income of -$6.6M, operating cash flow of -$2.5M, and free cash flow of -$2.5M (+12.8% YoY). On the balance sheet, AMST closed FY2025 with $2.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-06-30 | $110.5K | -$6.6M | -$2.5M | -$2.5M | $2.0M | — |
| FY2024 (FY) | 2024-06-30 | $166.9K | -$4.4M | -$2.8M | -$2.8M | $2.1M | — |
| FY2023 (FY) | 2023-06-30 | $845.0K | -$4.2M | -$3.2M | -$3.2M | — | — |
3. AMST Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs AMST stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Amesite Inc. (NASDAQ: AMST) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $0.57 (+1.48% 1D, market cap $3.7M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 3/20. Across 715 tracked Technology issuers, AMST ranks #569 in composite RQD confidence.
How does AMST compare to MNDR and WCT in the Technology sector?
Within the Technology sector (Computer Software: Prepackaged Software), AMST carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, MNDR (Mobile-health Network Solutions (Class A)) holds a E grade (27/100 RQD, P/E N/A, ROIC -35.0%, cap $3.6M) and WCT (Wellchange Holdings Company Limited (Class A)) posts a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $3.2M). Among the 5-stock peer group, AMST leads on earnings multiple (N/A) while AMST leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for AMST?
Per AMST's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001807166), Amesite Inc. generated $110.5K in revenue (-33.8% YoY), -$6.6M in net income, and -$2.5M in free cash flow against $2.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is AMST trading relative to its 50-day, 200-day, and 52-week technical levels?
AMST last traded at $0.57 (+1.48% on volume of 35,087 shares), positioning the stock -37.36% below its 50-day simple moving average ($0.91) and -56.49% below its 200-day simple moving average ($1.31). Across its 52-week range of $0.52 to $3.55, AMST sits at the 1.7% percentile with a 14-day RSI of 18.7 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.64).
ROARABLE RATING BRIEF • RQD 32/100 (E)
✓ SEC XBRL & RQD VERIFIED
AMST — Amesite Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-06-30
1. Roarable Rating Brief: What This Means to a Prospective Investor
Amesite Inc. (AMST) earns a live Roarable RQD composite score of 32/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $0.57 (+1.48% 1D, market capitalization $3.7M).
- Fundamental Cash Engine (9/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of —, operating margin of -60.0%, and free cash flow yield of —.
- Whale 13F & Options Flow (5/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (7/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 2/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Amesite Inc. (AMST) is a NASDAQ-listed operating company in the Computer Software: Prepackaged Software industry (Technology sector) with an equity market capitalization of $3.7M. The business operates with a gross margin of 0%, an operating margin of -60%, and a return on invested capital (ROIC) of -35% (free cash flow yield of 0%). Within the Computer Software: Prepackaged Software peer group, investor evaluation centers on operating leverage, unit margin durability, and capital allocation efficiency across market cycles.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-06-30), Amesite Inc. (AMST) reported $110.5K in annual revenue (up from $166.9K in FY2024, -33.8% YoY) and -$6.6M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($845.0K revenue, -$4.2M net income) through FY2025, AMST scaled operating cash flow to -$2.5M and free cash flow to -$2.5M, backed by $2.0M in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (E • RQD 32/100): Established market leader in Technology with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 5/20. With Fundamental Cash Engine at 9/20 and Institutional Whale Flow at 5/20, sustained execution supports upside toward the upper end of the $0.52 – $3.55 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Upstream and downstream dependencies are — Sector correlation data beyond the stated beta of 1.0 is — Second-order bottlenecks cannot be identified from the provided sources.
- Key Question #1: Can AMST sustain or expand its -60.0% operating margin and -35.0% ROIC against Computer Software: Prepackaged Software peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $110.5K and free cash flow of -$2.5M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is AMST's equity valuation to Technology capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
AMST Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Amesite Inc. (AMST) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE StockInvest.us • 1d ago
Amesite Stock Price Forecast. Should You Buy AMST? StockInvest.us report covering Amesite Inc. (AMST) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
Amesite Inc. Estimates – NASDAQ:AMST TradingView report covering Amesite Inc. (AMST) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 40d ago
Amesite Announces New Sales Win Under NurseMagic® Minimum Enterprise Pricing Model Company Estimates Agreements at New Pricing Level Can Generate Approximately 85% Gross Margin, Supporting Scalable Growth Across Post-Acute Care OrganizationsDETROIT, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasd
🔴 RISK WATCH Yahoo Finance • 169d ago
Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise Customer Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute CareDETROIT, May 18, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI-
🟡 MARKET WIRE Yahoo Finance • 190d ago
Amesite Announces Withdrawal of Registration Statement on Form S-1 DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST) (the “Company”), a leading developer of AI-powered enterprise solutions, today announced that it has filed with the U.S. Securities and Exchange Com
🟡 MARKET WIRE Yahoo Finance • 190d ago
Amesite reports $6M concurrent registered direct offering, private placement Amesite (AMST) announced that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share in a registered direct offering priced at-t
🟢 CATALYST Yahoo Finance • 167d ago
Amesite Stock Soars 150% on New Enterprise Deal. What to Know. Amesite shares soar on a major healthcare AI contract. But there are ample reasons to avoid chasing the momentum in AMST shares today.
🟡 MARKET WIRE Yahoo Finance • 168d ago
Amesite Rips 250% On Its Largest AI Healthcare Deployment Amesite secured a new enterprise customer representing an approximately 2,700-patient census for NurseMagic AI documentation.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
AMST Bull vs. Bear Conversation Board — What's Your Call at $0.57?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON AMST 🐻 33% BEARISH CONVICTION
QU QuantViper RQD DEBATE OPENER • Systematic Momentum Desk 🐂 BULLISH
🎯 Target: $0.65 (+16.1%)
📌 Pinned Debate The stock trades at $0.57 with a beta of 1.0 and a Altman Z-Score of 2.5, which places it outside the distress zone on that single metr
Picked up a starter position in AMST in my $100K Virtual Cash book at $0.56. The stock trades at $0.57 with a beta of 1.0 and a Altman Z-Score of 2.5, which places it outside the distress zone on that single metric.. Trading inside a $0.52–$3.55 52-week range with 0.0% FCF yield gives solid downside support if Computer Software: Prepackaged Software multiples expand this quarter.
EarningsSniper 🐂 BULL
@RedlineAuditor Shorting a 5/20 institutional whale-flow stock at $0.56 is dangerous when funds are rotating into Technology.
RE RedlineAuditor RQD DEBATE OPENER • Accounting Quality Watch 🐻 BEARISH
🎯 Target: $0.43 (-23.2%)
Spot @ $0.56 Revenue fell from $0.8M in FY 2023 to $0.1M in FY 2025 while operating losses persisted and ROIC stands at -35%.
Fading this rally in AMST at $0.56. Revenue fell from $0.8M in FY 2023 to $0.1M in FY 2025 while operating losses persisted and ROIC stands at -35%.. With a beta of 1.0 and the stock sitting at $0.56 (52-wk range $0.52–$3.55), the easy multiple expansion is already priced in.